NECTIN4 Amplification Is Frequent in Solid Tumors and Predicts Enfortumab Vedotin Response in Metastatic Urothelial Cancer.
Niklas KlümperNgoc Khanh TranStefanie ZschäbitzOliver HahnThomas BüttnerFlorian RoghmannChristian BolenzFriedemann ZengerlingConstantin SchwabDora NagyMarieta Ioana TomaGlen KristiansenHendrik HeersPhilipp IvanyiGuenter NiegischCamilla Marisa GrunewaldChristopher DarrArian FaridKatrin SchlackMahmoud AbbasCan AydogduJozefina CasuscelliTheresa MokryMichael MayrDora Niedersüß-BekeSteffen RauschDimo DietrichJonas SaalJoerg EllingerManuel RitterAbdullah AlajatiChristoph KuppeJoshua J MeeksFrancisco Emilio Vera-BadilloJosé Alberto Nakauma-GonzálezJoost BoormansKerstin JunkerArndt HartmannViktor GruenwaldMichael HudecekMarkus EcksteinPublished in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
amplifications are genomic predictors of EV responses and long-term survival in patients with mUC.